LifeArc funds Tranalab to expand its targeted drug-delivery platform for dengue
LifeArc awarded Tranalab a grant to expand its proprietary targeted drug-delivery technology platform to create therapeutic options against dengue.
News
LifeArc awarded Tranalab a grant to expand its proprietary targeted drug-delivery technology platform to create therapeutic options against dengue.